Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Non-syndromic cleft palate only (NSCPO) and non-syndromic cleft lip with or without cleft palate (NSCL/P) are distinct malformations with different or partially overlapping etiologies. While NSCL/P has been extensively studied, NSCPO remains relatively understudied. Emerging evidence suggests that long noncoding RNAs (lncRNAs) contribute to craniofacial development, potentially by regulating apoptosis.
Methods: This study investigated the role of FENDRR, a lncRNA previously found to be downregulated in NSCL/P, in NSCPO pathogenesis. FENDRR expression in NSCPO tissues was analyzed via RT-qPCR and fluorescence in situ hybridization. Apoptosis in human embryonic palatal mesenchymal (HEPM) cells was assessed using Western blotting, flow cytometry, and TUNEL assays. Bioinformatics, methylation-specific PCR, dual-luciferase reporter assays, and RNA immunoprecipitation were employed to examine FENDRR's interaction with MFN1.
Results: FENDRR was significantly reduced in NSCPO tissues. FENDRR knockdown disrupted mitochondrial dynamics and activated mitochondrial apoptosis in HEPM cells. Mechanistically, FENDRR formed an RNA-DNA triplex with the MFN1 promoter, recruiting TET2 to promote MFN1 transcription via promoter demethylation.
Conclusions: FENDRR enhances MFN1 expression, maintains mitochondrial fusion, and suppresses apoptosis in HEPM cells. This study provides novel insights into the regulatory role of lncRNAs in NSCPO pathogenesis and identifies FENDRR as a potential therapeutic target.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/odi.70035 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LncRNA FENDRR Inhibits Mitochondrial Apoptosis via TET2-Mediated DNA Demethylation of MFN1 in NSCPO.
Oral Dis
July 2025
Department of Orthodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
Background: Non-syndromic cleft palate only (NSCPO) and non-syndromic cleft lip with or without cleft palate (NSCL/P) are distinct malformations with different or partially overlapping etiologies. While NSCL/P has been extensively studied, NSCPO remains relatively understudied. Emerging evidence suggests that long noncoding RNAs (lncRNAs) contribute to craniofacial development, potentially by regulating apoptosis.
View Article and Find Full Text PDFNovel susceptibility gene SLC23A2 functions via PI3K-AKT-mTOR pathway in etiology of non-syndromic cleft palate.
J Hum Genet
September 2025
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of cleft lip and palate, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
The biological interactions between genetic and environmental modifiers play critical roles in the etiology of non-syndromic orofacial cleft (NSOC), but it is rarely studied. This study selected 47 environmental related genes from the metabolic pathways of smoking, drinking, hypoxia, and vitamins (including vitamin A, vitamin B9 (folic acid), vitamin C (ascorbic acid), vitamin D, and vitamin E), and test their associations with NSOC and its subtypes. We found that a novel gene SLC23A2, the vitamin C transporter gene is significantly associated with non-syndromic cleft palate only (NSCPO) (p = 3.
View Article and Find Full Text PDFIdentification of potential key targets and mechanisms underlying cleft palate induced by tobacco smoke exposure through multi-omics integrated Mendelian randomization analysis.
Ecotoxicol Environ Saf
July 2025
Department of Burns and Plastic Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515000, PR China. Electronic address:
Tobacco smoke (TS), a major indoor air pollutant, poses a significant health threat, notably increasing the incidence of congenital malformations, particularly cleft palate (CP). Although the mechanisms underlying TS-induced CP remain incompletely understood, this study provides novel insights by integrating multi-omics with Mendelian Randomization (MR) analyses. By utilizing two-sample MR and sensitivity analyses, we identified protective metabolites associated with CP, including glycerate, glycochenodeoxycholate, and isobutyrylcarnitine.
View Article and Find Full Text PDFExtract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating .
Plants (Basel)
April 2025
Faculty of Pharmacy, Gifu University of Medical Science, 4-3-3 Nijigaoka, Kani 509-0293, Gifu, Japan.
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate.
View Article and Find Full Text PDFModeling Krebs cycle from liver, heart and hepatoma mitochondria, supported Complex I as target for specific inhibition of cancer cell proliferation.
Front Oncol
March 2025
Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Introduction: The Krebs cycle (KC) is an important pathway for cancer cells because it produces reduced coenzymes for ATP synthesis and precursors for cellular proliferation. Described changes in cancer KC enzyme activities suggested modifications in the reactions that control the KC flux compared to normal cells.
Methods: In this work, kinetic metabolic models of KC of mitochondria from cancer (HepM), liver (RLM) and heart (RHM) to identify targets to decrease the KC flux were constructed from kinetic parameters (Vmax and Km) of enzymes here determined.